S. 3934 proposes the creation of a three-year nationwide project led by the Secretary of Health and Human Services to boost access to biosimilar biological products under Medicare. This demonstration project would evaluate the benefits of a shared savings payment plan for...
Simple Explanation
S. 3934 is a plan to try using special versions of medicines called biosimilars in Medicare, where doctors can earn extra money if they choose these medicines, but it won't cost patients more. The project will happen over three years, and it will help decide if using these medicines can keep costs the same while making sure people get good care.